Jin Sung Hong
FDA investigator
Appears on 2 documents from 2024 to 2025, mostly at sites in North Carolina. Most often cites written procedures; deviations (21 CFR 211.100).
- 2
- Documents on file
- 4.5
- Observations per 483
- 2024
- First seen
- 2025
- Most recent
What they cite most
From 12 observations- 21 CFR 211.100Written procedures; deviations2
- 21 CFR 211.22Responsibilities of quality control unit2
- 21 CFR 211.42Design and construction features2
- 21 CFR 211.56Sanitation2
- 21 CFR 211.122Materials examination and usage criteria1
- 21 CFR 211.142Warehousing procedures1
Activity by year
2024: 1, 2025: 1
Where
North Carolina 1 · Ohio 1
Often inspects with
Is Jin Sung Hong coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
2 documents, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2025-04-29 | 483 Axogen CorporationApr 29, 2025 · Vandalia, Ohio | Vandalia, Ohio | 7 | |
| 2024-04-05 | 483 Humacyte Global, IncApr 5, 2024 · Durham, North Carolina | Durham, North Carolina | 2 |
About this profile
What does Jin Sung Hong inspect?
Jin Sung Hong appears on 2 documents on file covering 2 sites, mostly in North Carolina.
What do they cite most often?
21 CFR 211.100 (written procedures; deviations), followed by 21 CFR 211.22 and 21 CFR 211.42.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Jin Sung Hong is dated Apr 29, 2025.